FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384933090> ?p ?o ?g. }

• W4384933090 abstract "Abstract Background A biosimilar is a biological medicine that contains a version of the active principle of a previously authorized original biological medicine (reference drug). Objective To evaluate the efficacy and safety of biosimilars in the treatment of immune-mediated inflammatory rheumatic diseases. Methods Retrospective observational and descriptive study of patients diagnosed with immune-mediated inflammatory rheumatic disease. Patients who had switched from a biological medicine to a biosimilar antiTNF and rituximab, for at least 24 weeks were included. Statistical tests such as the chi-square test were used to assess the independence of categorical variables, and Mann-Whitney U test was used to assess the independence between categorical and numerical variables, considering the heteroscedasticity of the groups. Results 364 patients who met the inclusion criteria were selected. 29.95% of patients discontinued treatment with the biosimilar: inefficacy in 87 patients (52 with primary failure and 35 with secondary failure), adverse effects in 18 patients and 4 patients discontinued it by their own decision. The mean disease activity at the beginning of the medication switch was 1.73 (± 0.93) in ASDAS, 8.73 (± 12.20) in DAPSA, and 2.60 (± 1.20) in DAS28, while at 24 weeks after the switch, the mean activity was 1.79 in ASDAS, 8.39 in DAPSA, and 2.62 in DAS28. Conclusions In our study, it was observed that 29.95% of the participants had to discontinue the use of the biosimilar drug, mainly due to its lack of efficacy, which exceeds the average reported in the current literature. Only 18 patients experienced some type of adverse effect, of which only 2 cases were severe. The mean activity levels measured by ASDAS, DAPSA, and DAS28 remained similar both at the beginning and at 24 weeks after the treatment switch, although patients with higher activity at the beginning of the switch presented higher activity levels at 24 weeks. Our data obtained in a real-life setting suggest that biosimilar drugs can be considered an effective and safe option in the treatment of inflammatory rheumatic diseases. However, it is important to note that there is a significant rate of discontinuation of biosimilar use." @default.
• W4384933090 created "2023-07-22" @default.
• W4384933090 creator A5001533235 @default.
• W4384933090 creator A5005114821 @default.
• W4384933090 creator A5006810159 @default.
• W4384933090 creator A5016111891 @default.
• W4384933090 creator A5019008650 @default.
• W4384933090 creator A5027442286 @default.
• W4384933090 creator A5028287919 @default.
• W4384933090 creator A5043196090 @default.
• W4384933090 creator A5044299094 @default.
• W4384933090 creator A5045007360 @default.
• W4384933090 creator A5065127011 @default.
• W4384933090 creator A5075857591 @default.
• W4384933090 creator A5087745137 @default.
• W4384933090 creator A5092508948 @default.
• W4384933090 date "2023-07-20" @default.
• W4384933090 modified "2023-09-26" @default.
• W4384933090 title "Experience of Mass Switching to Biosimilar Drugs in Patients with Immune-Mediated Inflammatory Rheumatic Diseases. Effectiveness and Safety. Intercambiosim Project" @default.
• W4384933090 cites W2342464058 @default.
• W4384933090 cites W2626689945 @default.
• W4384933090 cites W2732428835 @default.
• W4384933090 cites W2740132694 @default.
• W4384933090 cites W2745410586 @default.
• W4384933090 cites W2750911325 @default.
• W4384933090 cites W2753037786 @default.
• W4384933090 cites W2755962720 @default.
• W4384933090 cites W2767179430 @default.
• W4384933090 cites W2774189845 @default.
• W4384933090 cites W2790246629 @default.
• W4384933090 cites W2793866077 @default.
• W4384933090 cites W2885145206 @default.
• W4384933090 cites W2894042999 @default.
• W4384933090 cites W2900361267 @default.
• W4384933090 cites W2904646754 @default.
• W4384933090 cites W2945631565 @default.
• W4384933090 cites W3097044269 @default.
• W4384933090 doi "https://doi.org/10.21203/rs.3.rs-3154582/v1" @default.
• W4384933090 hasPublicationYear "2023" @default.
• W4384933090 type Work @default.
• W4384933090 citedByCount "0" @default.
• W4384933090 crossrefType "posted-content" @default.
• W4384933090 hasAuthorship W4384933090A5001533235 @default.
• W4384933090 hasAuthorship W4384933090A5005114821 @default.
• W4384933090 hasAuthorship W4384933090A5006810159 @default.
• W4384933090 hasAuthorship W4384933090A5016111891 @default.
• W4384933090 hasAuthorship W4384933090A5019008650 @default.
• W4384933090 hasAuthorship W4384933090A5027442286 @default.
• W4384933090 hasAuthorship W4384933090A5028287919 @default.
• W4384933090 hasAuthorship W4384933090A5043196090 @default.
• W4384933090 hasAuthorship W4384933090A5044299094 @default.
• W4384933090 hasAuthorship W4384933090A5045007360 @default.
• W4384933090 hasAuthorship W4384933090A5065127011 @default.
• W4384933090 hasAuthorship W4384933090A5075857591 @default.
• W4384933090 hasAuthorship W4384933090A5087745137 @default.
• W4384933090 hasAuthorship W4384933090A5092508948 @default.
• W4384933090 hasBestOaLocation W43849330901 @default.
• W4384933090 hasConcept C126322002 @default.
• W4384933090 hasConcept C177713679 @default.
• W4384933090 hasConcept C197934379 @default.
• W4384933090 hasConcept C23131810 @default.
• W4384933090 hasConcept C57658597 @default.
• W4384933090 hasConcept C59491497 @default.
• W4384933090 hasConcept C71924100 @default.
• W4384933090 hasConceptScore W4384933090C126322002 @default.
• W4384933090 hasConceptScore W4384933090C177713679 @default.
• W4384933090 hasConceptScore W4384933090C197934379 @default.
• W4384933090 hasConceptScore W4384933090C23131810 @default.
• W4384933090 hasConceptScore W4384933090C57658597 @default.
• W4384933090 hasConceptScore W4384933090C59491497 @default.
• W4384933090 hasConceptScore W4384933090C71924100 @default.
• W4384933090 hasLocation W43849330901 @default.
• W4384933090 hasOpenAccess W4384933090 @default.
• W4384933090 hasPrimaryLocation W43849330901 @default.
• W4384933090 hasRelatedWork W2169699670 @default.
• W4384933090 hasRelatedWork W2183235718 @default.
• W4384933090 hasRelatedWork W2464759024 @default.
• W4384933090 hasRelatedWork W2755778884 @default.
• W4384933090 hasRelatedWork W2977772374 @default.
• W4384933090 hasRelatedWork W2980813939 @default.
• W4384933090 hasRelatedWork W3120259217 @default.
• W4384933090 hasRelatedWork W3204021568 @default.
• W4384933090 hasRelatedWork W4379508757 @default.
• W4384933090 hasRelatedWork W4380149859 @default.
• W4384933090 isParatext "false" @default.
• W4384933090 isRetracted "false" @default.
• W4384933090 workType "article" @default.